This HTML5 document contains 132 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1159/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q40492547
rdf:type
wikibase:Item
schema:description
2005년 논문 artículu científicu espublizáu en 2005 article científic мақолаи илмӣ სამეცნიერო სტატია scienca artikolo tieteellinen artikkeli บทความทางวิทยาศาสตร์ 2005年學術文章 سائنسی مضمون artykuł naukowy 2005年學術文章 ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vitskapeleg artikkel wissenschaftlicher Artikel articol științific научная статья tudományos cikk 2005年學術文章 مقالهٔ علمی article scientific επιστημονικό άρθρο 2005 nî lūn-bûn artigo científico (publicado na 2005) مقالة علمية نشرت بتاريخ 24-11-2005 מאמר מדעי artikulong pang-agham 2005年學術文章 videnskabelig artikel (udgivet 2005) 2005年学术文章 vitenskapelig artikkel 2005年の論文 vědecký článek naučni članak scientific article мақолаи илмӣ bài báo khoa học научни чланак mokslinis straipsnis 2005年学术文章 article scientifique (publié 2005) наукова стаття, опублікована в листопаді 2005 2005年学术文章 2005年学术文章 artículo científico publicado en 2005 2005年学术文章 vetenskaplig artikel artigo científico (publicado na 2005) bilimsel makale articolo scientifico научна статия 2005年學術文章 wetenschappelijk artikel 2005年學術文章 artigo científico vedecký článok научни чланак գիտական հոդված teaduslik artikkel artikull shkencor
p:P577
wds:Q40492547-1C3ECFFF-7577-4E25-9D6A-8ED0F04ED302
wdt:P577
2005-11-24T00:00:00Z
p:P407
wds:Q40492547-59906786-9C59-4F23-9331-9A3079C46F43
wdt:P407
wd:Q1860
p:P2860
wds:Q40492547-0E122643-08EE-4CDD-9744-A6F87CA97B22 wds:Q40492547-5796D776-4962-41FE-9F8D-D9551AA1F011 wds:Q40492547-2C1DDF2F-5256-4156-8DB1-10BADC372E38 wds:Q40492547-3F8369A0-F5D5-41A5-BAA5-2191BEC67001 wds:Q40492547-C9B48490-A085-4247-8502-6D12F4FE00A1 wds:Q40492547-80959F2C-4541-4546-ACFF-0F00662F4EA6
wdt:P2860
wd:Q44362100 wd:Q42163493 wd:Q57578575 wd:Q42163501 wd:Q52072195 wd:Q50561182
p:P2093
wds:Q40492547-E6C16EDA-1168-465E-A00D-57B35DBCF183 wds:Q40492547-EDFC04D0-3B8A-440C-A93E-D5E2C162BCC3 wds:Q40492547-9616074B-13CF-4603-9BBD-1DED25D54F3F wds:Q40492547-B2459265-7E61-4B43-B8E7-1D8A64BFF267 wds:Q40492547-592EBE5A-67C3-49AF-9F8C-19233FAFD392 wds:Q40492547-4752A059-2857-4A59-ACC0-1D13BFA4773A wds:Q40492547-201953B7-4B3B-49B5-A2A6-C96ADE93CA16 wds:Q40492547-1B42F3E1-4862-4793-9863-C1440757FA29 wds:Q40492547-3F18A4A5-C920-4314-A73E-044479468011 wds:Q40492547-3BF6ABEB-6A3A-4AD0-AB32-22A6DC2F615E wds:Q40492547-12A5A868-4CF1-4EE7-B377-E40961AC1F5C wds:Q40492547-1AB51A3F-AFCF-45D7-9DC5-994C843C15A6
wdt:P2093
Gowri Ananthanarayanan Barbara A Burtness Leonard R Farber Daniel Zelterman Stephen Windsor Martin Abrams Saritha Salikooti Arlene D Hsu Gina G Chung Maysa M Abu-Khalaf Bruce G Haffty Michael P DiGiovanna
rdfs:label
Five-year update of an expanded phase II study of dose-dense and -intense doxorubicin, paclitaxel and cyclophosphamide (ATC) in high-risk breast cancer
skos:prefLabel
Five-year update of an expanded phase II study of dose-dense and -intense doxorubicin, paclitaxel and cyclophosphamide (ATC) in high-risk breast cancer
schema:name
Five-year update of an expanded phase II study of dose-dense and -intense doxorubicin, paclitaxel and cyclophosphamide (ATC) in high-risk breast cancer
p:P50
wds:Q40492547-7F43FAC8-0922-4977-BA11-032F327235C2 wds:Q40492547-94E93028-47F0-494A-8491-41AF5C3B59C5
wdt:P50
wd:Q56246697 wd:Q56547220
p:P1476
wds:Q40492547-6FDBDFA3-C814-449C-89D2-50AE68B6B7B6
wdt:P1476
Five-year update of an expanded phase II study of dose-dense and -intense doxorubicin, paclitaxel and cyclophosphamide (ATC) in high-risk breast cancer
p:P304
wds:Q40492547-62E9DA1A-D2E6-4B82-9E55-B1CEEA584840
wdt:P304
372-383
p:P31
wds:Q40492547-6B7E135F-20AD-406A-9283-7C77DC3A2114
wdt:P31
wd:Q13442814
p:P921
wds:Q40492547-4BD71406-5A82-42F5-AF49-D3F61C070A30 wds:Q40492547-99E1C147-4572-41BF-A7A1-5F03FED81A62
wdt:P921
wd:Q423762 wd:Q18936
p:P698
wds:Q40492547-B1517053-A25F-4460-8FD9-91DC975EF445
wdtn:P698
n11:16319508
wdt:P698
16319508
p:P1433
wds:Q40492547-1E69919E-F0F2-46F8-9C4A-635E4695371A
wdt:P1433
wd:Q2016300
p:P433
wds:Q40492547-E2C75259-7A4C-4E09-B0C5-1DF1050E57C0
p:P478
wds:Q40492547-C7E936F1-D9E5-4CC3-B242-D419EE48CA1F
wdt:P433
5
wdt:P478
69
p:P356
wds:Q40492547-98DE2421-1B22-413E-A287-91DA02487594
wdtn:P356
n10:000089991
wdt:P356
10.1159/000089991
p:P5875
wds:Q40492547-F68C410E-B4B4-4B3A-BD43-B55298C9CD28
wdt:P5875
7448552